RTP oncology firm G1 Therapeutics lands deal worth up to $46M for breast cancer drug
G1 Therapeutics has landed a deal with a China-based company to license an oncology drug. The deal could be worth as much as $46 million.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
